These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32386486)

  • 1. Pharmaceutical Approaches for Treatment of Hepatitis C virus.
    Milani A; Basimi P; Agi E; Bolhassani A
    Curr Pharm Des; 2020; 26(34):4304-4314. PubMed ID: 32386486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of resistance in HCV treatment.
    Vermehren J; Sarrazin C
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):487-503. PubMed ID: 23199507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
    Halfon P; Sarrazin C
    Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents.
    Murray M
    Clin Pharmacokinet; 2023 Oct; 62(10):1365-1392. PubMed ID: 37731164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral resistance and direct-acting antiviral agents for HCV.
    Aloia AL; Locarnini S; Beard MR
    Antivir Ther; 2012; 17(6 Pt B):1147-62. PubMed ID: 23188771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus resistance to protease inhibitors.
    Halfon P; Locarnini S
    J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All Oral Interferon-free Direct-acting Antivirals as Combination Therapies to Cure Hepatitis C.
    Shahid I; Ibrahim MM
    Curr Mol Med; 2018; 18(7):409-435. PubMed ID: 30608042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus.
    Kamal S; Shahzad A; Rehman K; Tariq K; Akash MSH; Imran M; Assiri MA
    Curr Med Chem; 2024; 31(15):2052-2072. PubMed ID: 37855348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus resistance to the new direct-acting antivirals.
    Esposito I; Trinks J; Soriano V
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1197-209. PubMed ID: 27384079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus.
    Pawlotsky JM
    Hepatology; 2011 May; 53(5):1742-51. PubMed ID: 21374691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Therapies for Hepatitis C Virus.
    Polenakovik H
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):119-32. PubMed ID: 27442378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new challenge in clinical practice: resistance to directly acting antivirals in hepatitis C treatment].
    Chen ZW; Hu P; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):165-9. PubMed ID: 27095757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of long-term hepatic and renal disease induced by HCV after direct-acting antivirals therapy.
    Arruda RM; Batista AD; Filgueira NA; Moura IF; Sette LH; Lopes EP
    J Bras Nefrol; 2021; 43(1):117-120. PubMed ID: 33022028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus.
    Li DK; Chung RT
    Methods Mol Biol; 2019; 1911():3-32. PubMed ID: 30593615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of HCV antiviral drug resistance.
    Welsch C; Zeuzem S
    Curr Opin Virol; 2012 Oct; 2(5):651-5. PubMed ID: 23006585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection.
    Zeisel MB; Crouchet E; Baumert TF; Schuster C
    Viruses; 2015 Nov; 7(11):5659-85. PubMed ID: 26540069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
    Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
    J Virol; 2019 May; 93(10):. PubMed ID: 30842319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New direct-acting antivirals' combination for the treatment of chronic hepatitis C.
    Asselah T; Marcellin P
    Liver Int; 2011 Jan; 31 Suppl 1():68-77. PubMed ID: 21205141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.